Sign In
Buy NMRD
$0.0002
+0 (+0%)
At Close: Jun 03, 2026
Diabetes Treatment: How Abbott Plans To Rival Dexcom With A New Device | Investor's Business Daily
04:57pm, Monday, 15'th Jun 2020
Abbott Laboratories is closing the competitive gap with Dexcom after gaining U.S. clearance for a next-generation diabetes treatment device.
U.S. Health Care Is in Flux. Here’s What Employers Should Do.
12:05pm, Monday, 15'th Jun 2020
The pandemic has rocked an already shaky system.
Blackstone To Invest $337 Million In Medtronic’s Diabetes Programs
06:28am, Monday, 15'th Jun 2020
Medtronic Plc (MDT) has announced that the Blackstone Group’s (BX) life sciences division will invest $337 million into the research and development of
Glytec, the only provider of insulin management software across the continuum of care, today published the first proof-of-concept study that combines
Data Presented at the American Diabetes Association 80th Scientific Sessions Propels Development of Novel Personalized Program for People with Diabetes MENLO PARK, Calif.--(BUSINESS WIRE)--New data pr
AI-Powered Metabolic Health Program from January.ai Accurately Predicts Individualized Glycemic Response in People with Type 2 Diabetes
12:00am, Saturday, 13'th Jun 2020
AI-powered metabolic health program from January.ai accurately predicts individualized glycemic response in people with type 2 diabetes.
Bigfoot Biomedical® Appoints Jim Malone MD Chief Medical Officer
04:44pm, Friday, 12'th Jun 2020
Press Release Bigfoot Biomedical, Inc. announced today the appointment of Dr. Jim Malone as Chief Medical Officer. Dr. Malone, an endocrinologist specializing in diabetes, spent 12 years in clinical p
Bigfoot Biomedical® Appoints Jim Malone MD Chief Medical Officer
02:10pm, Friday, 12'th Jun 2020
Bigfoot Biomedical, Inc. announced today the appointment of Dr. Jim Malone as Chief Medical Officer. Dr. Malone, an endocrinologist specializing in diabetes,...
Bigfoot Biomedical® Appoints Jim Malone MD Chief Medical Officer
12:00am, Friday, 12'th Jun 2020
Bigfoot Biomedical® Appoints recognized endocrinologist and clinical researcher Jim Malone MD as Chief Medical Officer
Nemaura Medical to Present at Credit Suisse 2020 Virtual Diabetes Sessions
11:00am, Wednesday, 10'th Jun 2020
Nemaura Medical, Inc. (NASDAQ: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing suga
